CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage.Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of Boonie Hat HCC, durable and ideal clinical benefits still cannot be achieved in plenty of patients with HCC.Therefore